Grippostad Rino 0.1% nasal drops 10 ml. vial

$9.00

Manufacturer: Germany

Purpose: Constricts blood vessels, reduces nasal congestion from colds, sinusitis.

SKU: MED58789 Category:

Description

Grippostad Rino 0.1% Nasal Drops 10 ml Vial

Ingredients:

Grippostad Rino 0.1% Nasal Drops contain the active ingredient xylometazoline hydrochloride which acts as a nasal decongestant.

Dosage:

For adults and children over 6 years: Apply 1-2 drops into each nostril 2-3 times a day. Do not exceed the recommended dosage.

Indications:

Grippostad Rino 0.1% Nasal Drops are indicated for the relief of nasal congestion associated with colds, allergies, or sinusitis.

Contraindications:

Do not use Grippostad Rino 0.1% Nasal Drops if you have hypersensitivity to xylometazoline or any other ingredients in the product. Consult a healthcare professional before use if you have heart disease, high blood pressure, diabetes, or thyroid problems.

Directions:

  • Tilt your head back slightly and apply the drops as directed.
  • Gently insert the dropper into the nostril and squeeze the vial to release the drops.
  • Avoid inhaling deeply while applying the drops.

Scientific Evidence:

Studies have shown that xylometazoline effectively reduces nasal congestion by constricting blood vessels in the nasal passages, leading to decreased swelling and congestion.

Additional Information:

Prolonged use of nasal decongestants like xylometazoline can lead to rebound congestion. It is recommended to use Grippostad Rino 0.1% Nasal Drops for short periods as directed by a healthcare professional.

Pharmacological Effects:

Xylometazoline works by stimulating alpha-adrenergic receptors in the nasal mucosa, leading to vasoconstriction and reduced blood flow, resulting in decreased nasal congestion and improved breathing.

Clinical Trials and Comparative Effectiveness:

In a comparative study, Grippostad Rino 0.1% Nasal Drops were found to be as effective as leading nasal decongestants in relieving nasal congestion with a similar onset of action. The study highlighted the favorable safety profile of xylometazoline in the treatment of nasal congestion.